title: Development of vanadate sensitive human erythrocytes insulin receptor tyrosine phosphatase assay.
abstract: The aim of this study was to investigate the effect of sodium orthovanadate on the alterations of human erythrocytes insulin receptor autophosphorylation. Human erythrocytes were incubated with insulin in a cell system and then lysed. The autophosphorylated insulin receptors were measured with the aid of a two-site immunofluorometric assay and using a monoclonal anti-insulin receptor antibody to label the insulin receptors and a monoclonal anti-phosphotyrosine antibody to assess tyrosine phosphorylation. When the erythrocytes were treated with insulin and then reincubated in insulin-free medium, vanadate completely inhibited insulin receptor dephosphorylation, although it had no effect on in vitro receptor autophosphorylation. Thus insulin receptor tyrosine phosphatase activity is postulated to be [% (autophosphorylated insulin receptors with vanadate - autophosphorylated insulin receptors without vanadate)/total insulin receptors] under overall steady conditions in a cell system. Using this assay, the insulin receptor tyrosine phosphatase activities of 25 control and 32 diabetic subjects were studied. There was no significant difference in insulin receptor tyrosine phosphatase activity between control subjects and diabetic subjects (0.173 +/- 0.062 vs 0.209 - +/- 0.057 autophosphorylated insulin receptors units/insulin receptors units). The assay used in this study requires only 0.6 ml of whole blood, and so should be a useful tool for detecting patients who are insulin-resistant due to abnormal insulin receptor tyrosine phosphatase activity.
authors.affiliation: Hyogo Institute of Clinical Research, Akashi, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Okada
authors.forename: M
authors.initials: M
authors.lastname: Yoshida
authors.forename: S
authors.initials: S
authors.lastname: Baba
authors.forename: K
authors.initials: K
authors.lastname: Shii
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D016466:CHO Cells; D006224:Cricetinae; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000201:enzymology; D004912:Erythrocytes / Q000187:drug effects / Q000201:enzymology*; D005063:Europium; D005470:Fluorometry; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D008875:Middle Aged; D010766:Phosphorylation; D017027:Protein Tyrosine Phosphatases / Q000097:blood / Q000378:metabolism*; D011972:Receptor, Insulin / Q000097:blood / Q000187:drug effects / Q000378:metabolism*; D014638:Vanadates / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D000911:Antibodies, Monoclonal; D007328:Insulin; D014638:Vanadates; D005063:Europium; D011972:Receptor, Insulin; D017027:Protein Tyrosine Phosphatases